Primary leptomeningeal histiocytic sarcoma in a patient with a good outcome: a case report and review of the literature

Journal of Medical Case Reports

Antonio Rueda Domínguez²  Ana Maria Serradilla Gil³  Andrés Sanz¹  Maite Delgado²  Elisabeth Pérez-Ruiz² 

[1] Pathology Department, Hospital Universitario Carlos Haya, Málaga, Spain;Division of Medical Oncology, REDISSEC, Hospital Costa del Sol, Autovía A-7, Km 187, Marbella, C.P. 29603, Spain;Division of Radiotherapy Oncology, Clinic Croasa, Málaga, Spain

关键词: Radiotherapy;    Multidisciplinary treatment;    Leptomeningeal sarcomas;    Histiocytic sarcoma;    Chemotherapy;   

Others  :  1181192
DOI  :  10.1186/1752-1947-7-127

 received in 2013-01-03, accepted in 2013-04-11,  发布年份 2013

【 摘 要 】

Introduction

Histiocytic sarcoma is a rare neoplasm with few cases reported in the literature of which some were diagnosed in animals. This neoplasm arises from abnormal reticuloendothelial system cell proliferation of histiocytes and has an aggressive behavior especially if located in the central nervous system. We present the first case of a patient with histiocytic sarcoma that involved the meninges and had a good course after multidisciplinary treatment.

Case presentation

Our patient was a 41-year-old Caucasian woman with no previous history of disease who started with systemic symptoms such as headache and chills. Magnetic resonance imaging with gadolinium contrast of the brain suggested a mass 1.5×2cm in diameter in the temporal lobe with a non-uniform vasogenic edema. This lesion was implanted in the meninges and surgery was the first treatment. The histological findings revealed a histiocytic sarcoma. The patient received concomitant chemoradiotherapy after surgery with good tolerance and currently lives without disease.

Conclusion

Although histiocytic sarcomas in the brain present an unusual location and have a poorer prognosis, we have identified the first primary leptomeningeal histiocytic sarcoma with a disease-free survival greater than 3 years following multidisciplinary treatment with surgery and chemotherapy and radiotherapy.

【 授权许可】

   
2013 Pérez-Ruiz et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Cheuk W, Walford N, Lou J, Lee AK, Fung CF, Au KH, Mak LS, Chan JK: Primary histiocytic lymphoma of the central nervous system. Am J Surg Pathol 2001, 25:1372-1379.
• [2]Cao M, Eshoa C, Schultz C, Black J, Zu Y, Chang CC: Primary central nervous system histiocytic sarcoma with relapse to mediastinum. Arch Pathol Lab Med 2007, 131:301-305.
• [3]Sun W, Nordberg M, Fowler M: Histiocytic sarcoma involving the central nervous system. Am J Surg Pathol 2003, 27:258-265.
• [4]Colovic N, Jurisic V, Colovic M: Malignant histiocytosis with central nervous system involvement and hepatic mucinous cystadenoma in a single patient with review of the literature. J BUON 2007, 12:539-542.
• [5]Torres CF, Korones D, Powers J, Vadasz AG: Primary leptomeningeal histiocytic lymphoma in a young child. Med and Pediat Oncology 1996, 27:547-550.
• [6]Molenaar FM, Breed EJ, Flach I, McCandlish IA, Pocknell AM, Strike T, Routh A, Taema M, Summers BA: Brain tumours in two Bactrian camels: a histiocytic sarcoma and a meningioma. Vet Rec 2009, 164:684-688.
• [7]Tamura S, Tamura Y, Nakamoto Y, Ozawa T, Uchida K: MR imaging of histiocytic sarcoma of the canine brain. Vet Radiol Ultrasound 2009, 50:178-181.
• [8]Uchida K, Morozumi M, Yamaguchi R, And TS: Diffuse leptomeningeal malignant histiocytosis in the brain and spinal cord of a Tibetan Terrier. Vet Pathol 2001, 38:219-222.
• [9]Ide T, Uchida K, Tamura S, Nakayama H: Histiocytic sarcoma in the brain of a cat. J Vet Med Sci 2010, 72:99-102.
• [10]Hirose S, Shimada S, Takebe Y, Tokuriki Y, Kawano H, Kubota T: Recurrent malignant histiocytosis with cerebrospinal involvement. Neurol Med Chir 1994, 34:233-236.
• [11]Vos JA, Abbdondanzo SL, Barekman C, Andriko JW, Miettinen M, Aguilera NS: Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163. Mod Pathol 2005, 18:693-794.
• [12]Pileri SA, Grogan TM, Harris NL, Banks P, Campo E, Chan JK, Favera RD, Delsol G, De Wolf-Peeters C, Falini B, Gascoyne RD, Gaulard P, Gatter KC, Isaacson PG, Jaffe ES, Kluin P, Knowles DM, Mason DY, Mori S, Müller-Hermelink HK, Piris MA, Ralfkiaer E, Stein H, Su IJ, Warnke RA, Weiss LM: Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 2002, 41:1-29.
• [13]Stupp R, Mason WP, Van den Bent M, Weller M, Fisher B, Taphorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352:987-996.
• [14]Hornick JL, Jaffe ES, Fletcher C: Extranodal histiocytic sarcoma. Clinicopathological analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol 2004, 28:1133.
• [15]Wu W, Sayit T, Vinters HV, Pope W, Mirsadraei L, Said J: Primary central nervous system histiocytic sarcoma presenting as a postradiation sarcoma: case report and literature review. Hum Pathol 2013., 26Epub ahead of print